Association between ADAMTS7 polymorphism and carotid artery plaque vulnerability
Hao-Wen Li1,2,3, Mi Shen4, Pei-Yi Gao4,5
1China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital.
Medicine
|October 26, 2019
Summary
Specific ADAMTS7 gene variants, rs7173743 and rs3825807, are linked to increased risk of vulnerable carotid plaques. These genetic factors influence atherosclerotic plaque stability, a key factor in artery disease.
Area of Science:
- Genetics and Cardiovascular Disease
- Molecular Biology and Atherosclerosis
Background:
- Genome-wide association studies (GWAS) have linked ADAMTS7 gene polymorphisms to atherosclerosis.
- The specific association between ADAMTS7 variants and the stability of atherosclerotic plaques remains poorly understood.
Purpose of the Study:
- To investigate the relationship between two ADAMTS7 variants (rs3825807 and rs7173743) and the risk of ischemic stroke or vulnerable atherosclerotic plaques.
- To determine if these ADAMTS7 polymorphisms are associated with carotid plaque vulnerability.
Main Methods:
- Observational study including ischemic stroke patients and healthy controls.
- High-resolution magnetic resonance imaging (MRI) to classify carotid plaques as vulnerable or stable.
- Genotyping of ADAMTS7 single nucleotide polymorphisms (SNPs) rs3825807 and rs7173743 using TaqMan assays and real-time PCR.
- Multivariate logistic regression analysis to adjust for confounding risk factors.
Main Results:
- The study included 326 ischemic stroke patients and 432 controls.
- Both ADAMTS7 variants, rs7173743 and rs3825807, were significantly associated with carotid plaque vulnerability.
- No association was found between these variants and the overall prevalence of ischemic stroke.
- The T/T genotype of rs7173743 and the A/A genotype of rs3825807 were identified as risk genotypes for vulnerable plaque susceptibility.
Conclusions:
- ADAMTS7 genetic variants rs3825807 and rs7173743 are associated with an increased risk of developing vulnerable carotid plaques.
- These findings highlight the role of ADAMTS7 in atherosclerotic plaque instability, independent of ischemic stroke prevalence.
Related Concept Videos
Coronary Artery Disease I: Introduction
829
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
829
Atherosclerosis I: Introduction
723
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
723
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
346
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
346
Coronary Artery Disease II: Pathophysiology
325
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
325
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
413
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
413
Cardiomyopathy III: Hypertrophic Cardiomyopathy
335
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
335


